Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sildenafil ODF vs Viagra in Healthy Males
NCT04391868Phase 1Withdrawn
- Sponsor
- Viatris
- Start
- Jan 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ASP-001 in erectile dysfunction (ED) (3 arms), sponsored by Viatris. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time and Maximum Observed Plasma Concentration. Planned start Jan 2021; status: withdrawn.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04391868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391868.